IP Library Granted Patent US 8,858,506
Granted Patent B2
US 8,858,506 · App. 13/759,785 · Granted Oct 14, 2014

Safety device for drug delivery devices and containers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,858,506
App. No.
13/759,785
Granted
Oct 14, 2014
Kind
B2
Abstract

A drug administration safety device having a label configured to be attached to a drug container such as a syringe or IV bag, an adhesive on the back face of the label, and a backing or substrate for holding the label and protecting the adhesive prior to the application of the label to the drug container. In one embodiment, the label includes a first drug name section in a first orientation, a second drug name section in a second orientation, a third drug name section in a third orientation, a drug concentration section, a variable information section, and a gradiation viewing section. The first orientation, second orientation, and third orientation are different from each other to enable a user to readily see the drug name regardless of the position and orientation of the drug container.

Claims (35)

1. A drug container labeling system comprising:

a drug container containing a drug;

a one-piece generally rectangular label having top, bottom and side edges attached to the container; and

the label including a first drug name section with the letters of the name of the drug in a first orientation aligned with one of the side edges, a second drug name section on the label with the letters of the name of the drug in a second orientation perpendicular to the first orientation, and a third drug name section on the label with the letters of the name of the drug in a third orientation inverted with respect to the second orientation.

2. The drug administration safety device of claim 1 in which the second drug name section is adjacent to the third drug name section.

3. The drug administration safety device of claim 1 in which the letters of the drug name in the first, second and third sections are positioned side-by-side.

4. The drug container labeling system of claim 1 in which the label includes a fourth drug name section with the letters of the name of the drug, and the orientation of the letters of the name of the drug in the fourth drug name section is different from the orientations of the letters of the name of the drug in the first, second and third drug name sections.

5. The drug container labeling system of claim 4 in which the letters of the name of the drug in the fourth drug name section are positioned one above the other.

6. The drug administration safety device of claim 5 in which the letters of the name of the drug in the fourth drug name section are oriented generally perpendicular to the letters of the name of the drug and the second and third drug name sections.

7. The drug container labeling system of claim 1 in which the label includes a drug concentration section with one or more of drug concentration, dosage strength and total amount of drug in the container.

8. The drug container labeling system of claim 7 in which the concentration section includes one or more shapes chosen from a sequence of different shapes associated with different drug concentrations.

9. The drug administration safety device of claim 7 in which the concentration section includes one or more shapes, colors, or shades chosen from a scheme of shapes, colors, and shades associated with different concentrations of the drug.

10. The drug container labeling system of claim 1 in which the label includes a variable information section with information chosen from the group consisting of barcodes, lot numbers, drug expiration dates, national drug code numbers, size of container, type of container, service code, date drug was formulated, recipient information, and information identifying the manufacturer of the drug container.

11. The drug container labeling system of claim 1 in which the label includes a graduation viewing section.

12. The drug container labeling system of claim 11 in which the graduation viewing section is configured to reveal portions of the container that have graduation markings.

13. The drug container labeling system of claim 11 in which the graduation viewing section is L-shaped.

14. The drug container labeling system of claim 1 in which the label is attached to the container by adhesive.

15. The drug container labeling system of claim 1 in which the container is chosen from the group consisting of an IV bag, a cassette, a drug vial, a syringe, and another container for holding a drug.

16. The drug container labeling system of claim 1 in which the first drug name section is positioned along a substantially horizontal axis of the label adjacent an edge of the label and second drug name section is positioned along a substantially vertical axis of the label along an opposite edge of the label and extends transversally to the orientation of the first drug name section.

17. The drug container labeling system of claim 1 in which the label is substantially transparent.

18. A drug administration safety device comprising:

a one-piece generally rectangular label having top, bottom and side edges configured to be attached to a container for holding a drug, the label including a first drug name section with the letters of the name of the drug in a first orientation aligned with one of the side edges, a second drug name section on the label with the letters of the name of the drug in a second orientation perpendicular to the first orientation, and a third drug name section on the label with the letters of the name of the drug in a third orientation inverted with respect to the second orientation.

19. The administration safety device of claim 18 in which the second drug name section is adjacent to the third drug name section.

20. The drug administration safety device of claim 18 in which the letters of the drug name in the first, second and third sections are positioned side-by-side.

21. The drug container labeling system of claim 18 in which the label includes a fourth drug name section including the letters of the name of the drug, and the orientation of the letters of the name of the drug in the fourth drug name section is different from the orientations of the letters of the name of the drug in the first, second and third drug name sections.

22. The drug administration safety device of claim 18 in which the label includes a drug concentration section with one or more of drug concentration, dosage strength and total amount of drug in the container.

23. The drug administration safety device of claim 22 in which the concentration section includes one or more shapes chosen from a sequence of different shapes associated with different drug concentrations.

24. The drug administration safety device of claim 18 in which the label includes a graduation viewing section is configured to reveal portions of the container that have graduation markings.

25. The drug administration safety device of claim 18 in which the label is substantially transparent.

26. A method of reducing the risk of error in the administration of a drug from a container to a patient where the drug has a name including a plurality of letters, comprising:

providing a container containing the drug; and

applying a one-piece generally rectangular label having top, bottom and side edges to the container, the label including a first drug name section with the letters of the name of the drug in a first orientation aligned with one of the side edges, a second drug name section on the label with the letters of the name of the drug in a second orientation perpendicular to the first orientation, and a third drug name section on the label with the letters of the name of the drug in a third orientation inverted with respect to the second orientation.

27. The method of reducing the risk of error in the administration of a drug of claim 26 in which the label includes a fourth drug name section with the letters of the name of the drug, and the orientation of the letters of the name of the drug in the fourth drug name section is different from the orientations of the letters of the name of the drug in the first, second and third drug name sections.

28. The method of reducing the risk of error in the administration of a drug of claim 26 in which the concentration section includes one or more shapes, colors, or shades chosen from a scheme of shapes, colors, and shades associated with different concentrations of the drug.

29. The method of reducing the risk of error in the administration of a drug in claim 26 which the container is chosen from the group consisting of an IV bag, a cassette, a drug vial, a syringe, and another container for holding a drug.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2021
From: RUNWAY ADVISORS, LLC
To: HIKMA PHARMACEUTICALS USA INC.
Reel/Frame 055270/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: PHARMEDIUM SERVICE, LLC
To: RUNWAY ADVISORS, LLC
Reel/Frame 053646/0281 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS - SECOND LIEN Recorded Nov 11, 2015
From: CREDIT SUISSE AG
To: PHARMEDIUM SERVICES, LLC
Reel/Frame 037097/0493 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS - FIRST LIEN Recorded Nov 11, 2015
From: JPMORGAN CHASE BANK, N.A.
To: PHARMEDIUM SERVICES, LLC
Reel/Frame 037097/0514 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS-FIRST LIEN Recorded Feb 20, 2014
From: PHARMEDIUM SERVICES, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 032301/0828 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS - SECOND LIEN Recorded Feb 20, 2014
From: PHARMEDIUM SERVICES, LLC
To: CREDIT SUISSE AG
Reel/Frame 032302/0275 →